Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before ...

Becton Dickinson (BDX) rose 2.4% in premarket trading as reports surface of potential separation of its $30 billion life ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $247.61 which represents a slight increase of $0.01 or 0.00% from the prior close of $247.6. The stock opened at $248.13 and ...

CarsonAllaria Wealth Management Ltd. bought a new stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by the ...

Shares of Becton Dickinson and Co (NYSE:BDX) climbed 3.3% following news that activist investor Starboard Value has acquired ...

Starboard Value has taken a stake in Becton Dickinson (BDX) and is pushing the medical technology company to sell its life sciences division, ...

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Becton Dickinson (BDX – Research Report), Idexx Laboratories ...

Becton Dickinson & Co. closed 3.80% short of its 52-week high of $251.99, which the company reached on February 3rd.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $249.08 which represents a slight increase of $0.38 or 0.15% from the prior close of $248.7. The stock opened at $248.68 and ...